G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2007
11/22/2007	DE112005002567T5 Eine neue Sonde und deren Verwendung in Bioaffinitäts-Analysen A new probe and its use in bioaffinity analyzes
11/22/2007	DE10357151B4 Vorrichtung zur Analyse von Flüssigkeiten A device for analysis of fluids
11/22/2007	DE102007019230A1 Probengefäß Sample vessel
11/22/2007	DE102006024355A1 Mikrofluidische Anordnung zur Detektion von in Proben enthaltenen chemischen, biochemischen Molekülen und/oder Partikeln Microfluidic arrangement for the detection of samples contained in chemical, biochemical molecules and / or particles
11/22/2007	DE102006023945A1 Verfahren und optisches Modul zum Auslesen von Biochips Method and optical module for reading biochips
11/22/2007	DE102006023943A1 Bio-cartridge for contamination-free filling of test chambers in biological analysis comprises an applicator with a filling cap having a filling cannula and a ventilating cannula and locking elements for positioning the cap
11/22/2007	DE102006023906A1 Verfahren zum Nachweis der Viabilität A method of detecting the viability
11/22/2007	DE102006023714A1 Vorrichtung und Verfahren zur selektiven Bestimmung der Menge von Ölnebel Device and method for the selective determination of the amount of oil mist
11/22/2007	DE102006023175A1 In vitro Verfahren zur Diagnose und Frühdiagnose von neurodegenerativen Erkrankungen In vitro method for the diagnosis and early diagnosis of neurodegenerative diseases
11/22/2007	DE102006022877A1 Verfahren zur Bestimmung der Viabilität von Zellen in Zellkulturen A process for determining the viability of cells in cell cultures
11/22/2007	DE102006021406A1 In vitro Verfahren zur Erkennung und Früherkennung und zur begleitenden Kontrolle der Therapie von arznei- und suchtmittelinduzierten Leberschäden In vitro method for the detection and early detection and control for concomitant therapy of medicated and drug-induced liver injury
11/22/2007	CA2676442A1 Methods for detection of target on responsive polymeric biochips
11/22/2007	CA2652455A1 Iap bir domain binding compounds
11/22/2007	CA2652452A1 Neutralizing antibodies to influenza viruses
11/22/2007	CA2652324A1 Test-sensor packaging
11/22/2007	CA2652043A1 Biomarkers for detection and diagnosis of head and neck squamous cell carcinoma
11/22/2007	CA2651914A1 Information characterization system and methods
11/22/2007	CA2651847A1 Detecting diastolic heart failure by protease and protease inhibitor plasma profiling
11/22/2007	CA2651597A1 Detection of inflammatory disease and composition for prevention or treatment of inflammatory disease
11/22/2007	CA2651564A1 Detection method and kit
11/22/2007	CA2650949A1 Electrochemical test sensor with reduced sample volume
11/22/2007	CA2650880A1 Abnormal output detection system for a biosensor
11/22/2007	CA2647102A1 Ras mutation and compositions and methods related thereto
11/21/2007	EP1857819A1 Method of measuring exposure dosage of ionizing radiation
11/21/2007	EP1857818A1 Diagnostic and therapeutic uses of peptides for pre-forms of type 2 diabetes and conditions associated therewith
11/21/2007	EP1857817A1 Screening method
11/21/2007	EP1857816A1 Method of screening therapeutic agent for irritable bowel syndrome
11/21/2007	EP1857809A1 Method of measuring coating amount and method of estimating elution behavior
11/21/2007	EP1857802A1 Automatic quality control method for the water-vapour cycles in power stations
11/21/2007	EP1857554A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
11/21/2007	EP1857553A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
11/21/2007	EP1857551A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
11/21/2007	EP1857546A1 An animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
11/21/2007	EP1857538A1 Microscope apparatus and cell observation method
11/21/2007	EP1857464A2 Chlamydia antigens
11/21/2007	EP1857119A1 Agent for prevention/treatment of neurodegenerative disease
11/21/2007	EP1856540A1 Method for determining coagulation activation and device for carrying out said method
11/21/2007	EP1856539A2 Methods of predicting therpeutic response in atopic dermatitis to il-31 antagonists
11/21/2007	EP1856538A1 Determination of short-chain srl-alcohol dehydrogenase (dhrs4) as biomarker of inflammations and infections
11/21/2007	EP1856537A1 Method for checking and controlling the mammalian lactic acid fermentation process/aerobic glucose fermentation metabolic pathway in mammalian organism
11/21/2007	EP1856536A1 Diagnosis method of hepatic steatosis using biochemical markers
11/21/2007	EP1856535A2 Reagents and methods for use in cancer diagnosis, classification and therapy
11/21/2007	EP1856534A2 Peptides for detection of antibody to porcine reproductive respiratory syndrome virus
11/21/2007	EP1856533A1 Microglia facilitated amyloidogenesis assay
11/21/2007	EP1856532A2 Methods and compositions for the treatment of lipid-associated disorders
11/21/2007	EP1856531A2 Method for diagnosing multiple sclerosis
11/21/2007	EP1856530A2 Fluorous-based microarrays
11/21/2007	EP1856529A2 Compositions for use as a signal generation component and methods of using same
11/21/2007	EP1856528A2 Compositions and methods for purifying and crystallizing molecules of interest
11/21/2007	EP1856527A2 Regulators of protein misfolding and aggregation and methods of using the same
11/21/2007	EP1856526A2 Thioredoxin interacting protein (txnip) as regulator of vascular function
11/21/2007	EP1856525A1 Disc substrates for combinatorial chemistry
11/21/2007	EP1856524A2 Methods and compositions for preventing and treating a disease related to glycan dysregulation
11/21/2007	EP1856523A2 Antigen specific lymphocytes, compositions thereof, and methods for isolation and preparation thereof
11/21/2007	EP1856522A1 Assays for agents with selective cytotoxicty to hdac resistant cell lines
11/21/2007	EP1856521A2 Modulation of th2 lineage commitment by t-bet
11/21/2007	EP1856520A2 Microwave accelerated plasmonics
11/21/2007	EP1856519A2 Method for modification of a synthetically generated assay using measured whole crude properties
11/21/2007	EP1856515A1 Electric device for determining gaseous substances comprising an organic monolayer as the sensing layer
11/21/2007	EP1856510A1 Device and method for the optical scanning of an elongated textile material
11/21/2007	EP1856503A2 Dual path immunoassay device
11/21/2007	EP1856311A2 A method for identifying skin care composition-resistant skin-binding peptides
11/21/2007	EP1856281A2 Gitr antibodies for the diagnosis of nsclc
11/21/2007	EP1856276A1 Methods for assessing suitability of cancer patients for treatment with histone deacetylase inhibitors
11/21/2007	EP1856274A2 Systemic markers for asthma and analogous diseases
11/21/2007	EP1856151A2 Estrogen receptor structure
11/21/2007	EP1856149A2 Cxcr3 is a gliadin receptor
11/21/2007	EP1856147A1 A molecule and chimeric molecules thereof
11/21/2007	EP1856144A2 Method for the redox potential-dependent detection of target molecules by interactive peptides
11/21/2007	EP1855717A1 Surface-located streptococcus pneumoniae polypeptides
11/21/2007	EP1855663A2 Methods for modulating macrophage proliferation in ocular disease using polyamine analogs
11/21/2007	EP1855595A2 Pharmaceutical liposomal compositions
11/21/2007	EP1855591A2 Apparatus and methods for analyzing body fluid samples
11/21/2007	EP1855586A2 Methods and apparatuses for noninvasive determinations of analytes
11/21/2007	EP1855525A2 Zebrafish models for alzheimer's disease
11/21/2007	EP1751549B1 Orthodontic indicator
11/21/2007	EP1743038A4 Mn/ca ix/ ca9 and renal cancer prognosis
11/21/2007	EP1728074B1 Method for extracting intracellular complexes or compounds from a sample containing cells in a liquid suspension
11/21/2007	EP1700096A4 Detection of conformationally altered proteins and prions
11/21/2007	EP1680011A4 Determinationof phenotype of cancer and of precancerous tissue
11/21/2007	EP1651955A4 Methods for detecting and analyzing n-glycolylneuraminic acid (neu5gc) in biological materials
11/21/2007	EP1634061A4 Method and system for measuring lactate levels in vivo
11/21/2007	EP1625233B1 Reducing microarray variation with internal reference spots
11/21/2007	EP1595143A4 The detection and identification of saxiphilins using saxitoxin-biotin conjugates
11/21/2007	EP1585972A4 Methods and compositions for diagnosing and monitoring transplant rejection
11/21/2007	EP1578920A4 Composition and method for modulating an inflammatory response
11/21/2007	EP1578904A4 Systems, methods and kits for remote genetic analysis and consultation
11/21/2007	EP1545317B1 Liquid sampler and method
11/21/2007	EP1543324B1 Methods and compositions for grafting functional loops into a protein
11/21/2007	EP1525466A4 Transgenic mammals expressing polyglutamine
11/21/2007	EP1525223B1 Ox40 (=cd134) receptor agonists and therapeutic use
11/21/2007	EP1516189B1 Diagnostic and therapeutic use of ensadin-0581 gene and protein for neurodegenerative diseases
11/21/2007	EP1472518A4 Automatic threshold setting and baseline determination for real-time pcr
11/21/2007	EP1425586B1 Mass labels
11/21/2007	EP1395830B1 Bcmp-101, a cancer associated protein
11/21/2007	EP1385000B1 Method for making biochip
11/21/2007	EP1350112B1 Methods for the treatment of ibs
11/21/2007	EP1338359B1 Process for producing, through strip casting, raw alloy for nanocomposite type permanent magnet
11/21/2007	EP1320571B1 3-spiro-cyanin fluorochromes and their use in bioassays
11/21/2007	EP1282723A4 Methods for detecting for the presence of tumor cells and for screening for anti-tumor agents

1 ... 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 1578 ... 3937